63 related articles for article (PubMed ID: 16760325)
1. Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.
Chen M; Hisatomi Y; Furumoto A; Kawakami K; Masaki H; Nagatake T; Sueyasu Y; Iwanaga T; Aizawa H; Oishi K
Clin Vaccine Immunol; 2007 Feb; 14(2):139-45. PubMed ID: 17167035
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of general immunisation of infants and young children with the heptavalent conjugated pneumococcal vaccine.
Antony K; Pichlbauer E; Stürzlinger H
GMS Health Technol Assess; 2005 Nov; 1():Doc05. PubMed ID: 21289926
[TBL] [Abstract][Full Text] [Related]
3. Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies.
Inostroza J; Villanueva S; Mason K; Leiva LE; Sorensen RU
Clin Diagn Lab Immunol; 2005 Jun; 12(6):722-6. PubMed ID: 15939746
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal antibody response in children with recurrent respiratory tract infections: A descriptive study.
Ceuppens F; Meyts I; Bossuyt X; De Boeck K
Arch Pediatr; 2024 May; ():. PubMed ID: 38811264
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study.
Bahuaud M; Bodilis H; Malphettes M; Maugard Landre A; Matondo C; Bouscary D; Batteux F; Launay O; Fermand JP
Heliyon; 2017 Nov; 3(11):e00441. PubMed ID: 29159320
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France].
Black S; Shinefield H; Cohen R; Floret D; Gaudelus J; Olivier C; Reinert P
Arch Pediatr; 2004 Jul; 11(7):843-53. PubMed ID: 15234383
[TBL] [Abstract][Full Text] [Related]
7. Prevenar vaccination: review of the global data, 2006.
Center KJ
Vaccine; 2007 Apr; 25(16):3085-9. PubMed ID: 17287048
[TBL] [Abstract][Full Text] [Related]
8. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
Navarro D; Escribano A; Cebrián L; Gimeno C; García-Maset L; García-de-Lomas J;
Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
[TBL] [Abstract][Full Text] [Related]
9. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
10. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
Huebner RE; Mbelle N; Forrest B; Madore DV; Klugman KP
Vaccine; 2004 Jul; 22(21-22):2696-700. PubMed ID: 15246599
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
12. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
Balmer P; Borrow R; Arkwright PD
Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
[TBL] [Abstract][Full Text] [Related]
13. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study.
Goldblatt D; Hussain M; Andrews N; Ashton L; Virta C; Melegaro A; Pebody R; George R; Soininen A; Edmunds J; Gay N; Kayhty H; Miller E
J Infect Dis; 2005 Aug; 192(3):387-93. PubMed ID: 15995951
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.
Ekström N; Ahman H; Verho J; Jokinen J; Väkeväinen M; Kilpi T; Käyhty H
Infect Immun; 2005 Jan; 73(1):369-77. PubMed ID: 15618174
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
